Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Ads

You May Also Like

Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval

                                                   --   Vifor Pharma Commits to Exclusive Distribution of Vadadustat to Fresenius Medical Care North America ...

Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update

SEATTLE, May 09, 2016 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (NASDAQ:ONTY), a clinical-stage biopharmaceutical company, ...